Testing effectiveness (Phase 2)Study completedNCT01719549What this trial is testingDovitinib for Gastric Cancer With FGFR2 Amplification: GASDOVI-1Who this might be right forGastric Cancer Asan Medical Center 19
Testing effectiveness (Phase 2)Study completedNCT01238055What this trial is testingSunitinib + Docetaxel as Second-line Treatment in Gastric CancerWho this might be right forAdvanced Gastric Cancer Samsung Medical Center 116
Testing effectiveness (Phase 2)WithdrawnNCT02274012What this trial is testingTrial of Afatinib in Combination With Weekly Paclitaxel in the Second Line TreatmentWho this might be right forHER-2 Positive Gastric CancerGastrooesophageal CancerEsophageal Cancer Columbia University
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06592287What this trial is testingThe Combination of Adebrelimab, Apatinib, and Lrinotecan Liposome for Second-line Treatment of Advanced Gastric CancerWho this might be right forAdvanced Gastric Cancer Xianglin Yuan 66
Early research (Phase 1)UnknownNCT05171530What this trial is testingLenvatinib With Taxane Drugs Treatment for Advanced Gastric CancerWho this might be right forHER2-negative Advanced Gastric Cancer Ruijin Hospital 19
Testing effectiveness (Phase 2)Looking for participantsNCT04592211What this trial is testingPembrolizumab, Olaparib, Recurrent/Advanced Gastric and Gastro-esophageal Junction(GEJ) CancerWho this might be right forGastric Cancer Stage IV Yonsei University 71
Testing effectiveness (Phase 2)WithdrawnNCT03818997What this trial is testingCombination of Targeted and Immunotherapy for Advanced Biliary Tract and Esophagogastric Gastric CancerWho this might be right forEsophageal CancerBiliary Tract CancerGastroEsophageal Cancer+1 more European Organisation for Research and Treatment of Cancer - EORTC
Large-scale testing (Phase 3)Study completedNCT02898077What this trial is testingPaclitaxel With or Without Ramucirumab (LY3009806) in Participants With Gastric or Gastroesophageal CancerWho this might be right forGastroesophageal Junction AdenocarcinomaGastric Adenocarcinoma Eli Lilly and Company 440
Testing effectiveness (Phase 2)Ended earlyNCT04363801What this trial is testingDKN-01 in Combination With Tislelizumab ± Chemotherapy in Patients With Gastric or Gastroesophageal CancerWho this might be right forGastric CancerGastric AdenocarcinomaGastroEsophageal Cancer Leap Therapeutics, Inc. 247
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06706895What this trial is testingA Single-arm, Single-center Phase II Clinical Study on the Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection Combined With Fruquintinib Capsules in the Second-line Treatment of Patients With Advanced Gastric CancerWho this might be right forAdvanced Gastric CancerPaclitaxel Polymeric Micelles for InjectionFruquintinib Capsules Shanghai Zhongshan Hospital 21
Large-scale testing (Phase 3)Study completedNCT00486954What this trial is testingLapatinib in Combination With Weekly Paclitaxel in Patients With ErbB2 Amplified Advanced Gastric CancerWho this might be right forNeoplasms, Gastrointestinal Tract GlaxoSmithKline 273
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07361991What this trial is testingIBI363 Plus Bevacizumab With or Without Nab-Paclitaxel for Second-Line Treatment of Advanced Gastric CancerWho this might be right forAdvan'ce'dAdvanced The First Affiliated Hospital of Zhengzhou University 50
Testing effectiveness (Phase 2)Ended earlyNCT02241720What this trial is testingRegorafenib Second Line Treatment of Metastatic or Advanced Upper GI CancersWho this might be right forUpper GI Cancer University of Utah 5
Testing effectiveness (Phase 2)UnknownNCT01095120What this trial is testingTesetaxel as Second-line Therapy for Patients With Advanced Gastric CancerWho this might be right forAdenocarcinoma of the StomachAdenocarcinoma of Esophagogastric Junction Genta Incorporated 27
Early research (Phase 1)UnknownNCT03026881What this trial is testingFluzoparib Given in Combination With Apatinib and Paclitaxel in Gastric Cancer PatientsWho this might be right forRecurrent and Metastatic Gastric Cancer Jiangsu HengRui Medicine Co., Ltd. 24
Testing effectiveness (Phase 2)UnknownNCT03030937What this trial is testingClinical Trial to Compare Apatinib Plus Irinotecan Versus Single Irinotecan as Second-line Treatment in AGC or EGJAWho this might be right forAdvanced Gastric Cancer Adenocarcinoma of Esophagogastric Junction Fujian Cancer Hospital 74
Testing effectiveness (Phase 2)WithdrawnNCT00209612What this trial is testingPhase I/II Study of Paclitaxel Plus CPT-11 in Pts. With 2nd Line Chemotherapy of Inoperable or Recurrent GC.Who this might be right forGastric Cancer Hokkaido Gastrointestinal Cancer Study Group 40
Testing effectiveness (Phase 2)Looking for participantsNCT07320586What this trial is testingCarilizumab and Albumin Paclitaxel for Second-line Treatment of Advanced Gastric CancerWho this might be right forGastric CancerSecond-line Therapy Shandong Tumor Hospital 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07045805What this trial is testingPhase II Study of QL1706 Combined With Paclitaxel and Bevacizumab for Second-Line Immune Rechallenge in Gastric CancerWho this might be right forGastric Cancer (GC) The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 66
Large-scale testing (Phase 3)Looking for participantsNCT07362186What this trial is testingLM-108 in Combination With Toripalimab Versus Paclitaxel Injection for the Treatment of Subjects With CCR8-Positive Gastric and Gastroesophageal Junction AdenocarcinomaWho this might be right forLocally Advanced or Metastatic GC and GCJ Adenocarcinoma LaNova Medicines Limited 400